4876 - 4900 of 5662 Results
Title
Year
-
OPENTitle: BDNF polymorphism associates with decline in set shifting in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1605.e1End Page: 1605.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.08.023Citation Count: 44
- Cadherin‐8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuits2014OPENTitle: Cadherin‐8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuitsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 523Issue #: 1Start Page: 75End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23666Best OA location URL: https://europepmc.org/articles/pmc4232472?pdf=renderCitation Count: 35
- Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFADmice, an animal model of Alzheimer's disease2014OPENTitle: Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFADmice, an animal model of Alzheimer's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 132Issue #: 2Start Page: 254End Page: 262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12935Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12935Citation Count: 40
-
OPENTitle: Course of psychiatric symptoms and global cognition in early Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 12Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801Best OA location URL: https://europepmc.org/articles/pmc4166362?pdf=renderCitation Count: 113
- Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected Relatives2014OPENTitle: Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected RelativesJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 24Issue #: 2Start Page: 238End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-014-9756-xBest OA location URL: https://europepmc.org/articles/pmc4331260?pdf=renderCitation Count: 27
-
OPENTitle: Olfactory dysfunction in incidental Lewy body disease and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 11Start Page: 1260End Page: 1262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.08.006Best OA location URL: https://europepmc.org/articles/pmc4835172?pdf=renderCitation Count: 71
- Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease2014OPENTitle: Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fnagi.2014.00213Best OA location URL: https://europepmc.org/articles/pmc4132266?pdf=renderCitation Count: 21
- Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorder2014OPENTitle: Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorderJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2014.00627Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2014.00627/pdfCitation Count: 52
- Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS2014OPENTitle: Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRSJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 11Start Page: 1135End Page: 1139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.08.001Best OA location URL: https://europepmc.org/articles/pmc4252982?pdf=renderCitation Count: 46
- Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synuclein2014OPENTitle: Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 41
-
OPENTitle: Independent Spanish Validation of the Unified Dyskinesia Rating ScaleJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 3Start Page: 213End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12065Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12065Citation Count: 8
- Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants2014OPENTitle: Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participantsJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 16Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/gim.2014.55Best OA location URL: https://europepmc.org/articles/pmc4682659?pdf=renderCitation Count: 7
-
OPENTitle: Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body ClearingJournal Name: CellPublisher: Elsevier BVVol: 158Issue #: 4Start Page: 945End Page: 958Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2014.07.017Best OA location URL: http://www.cell.com/article/S0092867414009313/pdfCitation Count: 862
- Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study2014OPENTitle: Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 10Start Page: 2743End Page: 2758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awu201Best OA location URL: https://academic.oup.com/brain/article-pdf/137/10/2743/11140806/awu201.pdfCitation Count: 139
- Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry2014OPENTitle: Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass SpectrometryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/srep05797Best OA location URL: https://www.nature.com/articles/srep05797.pdfCitation Count: 146
-
OPENTitle: Naltrexone for impulse control disorders in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 9Start Page: 826End Page: 833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000729Best OA location URL: https://europepmc.org/articles/pmc4155050?pdf=renderCitation Count: 79
-
OPENTitle: A brain network response to sham surgeryJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 8Start Page: 3285End Page: 3288Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci77193Best OA location URL: http://www.jci.org/articles/view/77193/files/pdfCitation Count: 2
-
OPENTitle: A GCase Chaperone Improves Motor Function in a Mouse Model of SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 840End Page: 856Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0294-xBest OA location URL: https://europepmc.org/articles/pmc4391384?pdf=renderCitation Count: 93
- Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats2014OPENTitle: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 ratsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 505End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011Best OA location URL: https://europepmc.org/articles/pmc5289148?pdf=renderCitation Count: 45
- ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo2014OPENTitle: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In VivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 22Issue #: 10Start Page: 1753End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/mt.2014.129Best OA location URL: http://www.cell.com/article/S1525001616307808/pdfCitation Count: 80
- Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study2014OPENTitle: Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography studyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 112Issue #: 7Start Page: 1739End Page: 1747Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00383.2014Best OA location URL: https://europepmc.org/articles/pmc4157173Citation Count: 76
- Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease2014OPENTitle: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 462End Page: 469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004Best OA location URL: https://europepmc.org/articles/pmc4268125?pdf=renderCitation Count: 47
-
OPENTitle: A Neurodegenerative Vascular Burden Index and the Impact on CognitionJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00161Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00161/pdfCitation Count: 14
- Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice2014OPENTitle: Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic miceJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 29Start Page: 10732End Page: 10737Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1321785111Best OA location URL: https://www.pnas.org/content/pnas/111/29/10732.full.pdfCitation Count: 281
-
OPENTitle: Noninvasive optical inhibition with a red-shifted microbial rhodopsinJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 8Start Page: 1123End Page: 1129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3752Best OA location URL: https://dspace.mit.edu/bitstream/1721.1/98648/1/920678211-MIT.pdfCitation Count: 493